Prioritizing Combinational Drug Screening: A Ranking System for In Vitro Drug Combinations in Neurofibromatosis Type 1

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Selumetinib—A Comprehensive Review of the New FDA-Approved Drug for Neurofibromatosis2024 · 7 citations
2. 2Combination therapy in combating cancer2017 · 2,580 citations
3. 3ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma2024 · 102 citations
4. 4Carfilzomib: A Promising Proteasome Inhibitor for the Treatment of Relapsed and Refractory Multiple Myeloma2021 · 95 citations